Clinical Data at Diagnosis of the Two Groups of Ph-neg ET Patients
| . | Group A . | Group B . | P Value . |
|---|---|---|---|
| . | BCR-ABL Negative . | BCR-ABL Positive . | . |
| . | n = 13 . | n = 12 . | . |
| Male/female | 8/5 | 4/8 | |
| Age (yr) | 52.1 ± 16.8 | 64.5 ± 10.4 | 0.04 |
| Range | 28-81 | 45-82 | |
| Follow-up (mo) | |||
| Median | 20 | 22.5 | |
| Range | 8-87 | 17-63 | |
| Symptoms | |||
| Dizziness | 4 | 5 | |
| Bleeding | 2 | 1 | |
| Thrombosis | 0 | 1 | |
| Tinitus | 1 | 0 | |
| Spleen | |||
| Unpalpable | 8 | 10 | |
| Palpable | 5 | 2 | |
| <3 cm | 2 | 1 | |
| ≥3 cm | 3 | 1 |
| . | Group A . | Group B . | P Value . |
|---|---|---|---|
| . | BCR-ABL Negative . | BCR-ABL Positive . | . |
| . | n = 13 . | n = 12 . | . |
| Male/female | 8/5 | 4/8 | |
| Age (yr) | 52.1 ± 16.8 | 64.5 ± 10.4 | 0.04 |
| Range | 28-81 | 45-82 | |
| Follow-up (mo) | |||
| Median | 20 | 22.5 | |
| Range | 8-87 | 17-63 | |
| Symptoms | |||
| Dizziness | 4 | 5 | |
| Bleeding | 2 | 1 | |
| Thrombosis | 0 | 1 | |
| Tinitus | 1 | 0 | |
| Spleen | |||
| Unpalpable | 8 | 10 | |
| Palpable | 5 | 2 | |
| <3 cm | 2 | 1 | |
| ≥3 cm | 3 | 1 |